SCHEMBL25725354

SCHEMBL25725354

CCCC1(CCC)CN(c2ncnc3ccc(C#Cc4ccccc4)cc23)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 2/20 0.41
▸ IP6K1 Q92551 1/20 0.39
▸ IP6K3 Q96PC2 1/20 0.39
▸ IP6K2 Q9UHH9 1/20 0.39
▸ ALDH1A1 P00352 7/20 0.39
▸ CYP1A2 P05177 7/20 0.39
▸ CYP3A4 P08684 7/20 0.39
▸ CLK4 Q9HAZ1 5/20 0.39
▸ MEN1 O00255 4/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ HIF1A Q16665 4/20 0.39
▸ USP2 O75604 3/20 0.39
▸ HTT P42858 3/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ ADORA2A P29274 1/20 0.39
▸ ACHE P22303 2/20 0.38
▸ BACE1 P56817 2/20 0.38
▸ AURKA O14965 2/20 0.38
▸ LMNA P02545 3/20 0.37
▸ TSHR P16473 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25630514 0.81 KIT (0.44) IP6K1IP6K3IP6K2ALDH1A1CYP1A2
SCHEMBL25630777 0.81 HRH4 (0.55) EGFRALDH1A1HTTNPSR1LMNA
SCHEMBL25725389 0.79 ALDH1A1 (0.47) EGFRALDH1A1CYP1A2CYP3A4CLK4
SCHEMBL25233084 0.78 CYP1A2 (0.47) EGFRIP6K1IP6K3IP6K2ALDH1A1
SCHEMBL31501697 0.78 CYP1A2 (0.47) EGFRIP6K1IP6K3IP6K2ALDH1A1
SCHEMBL25630734 0.75 CYP1A2 (0.42) EGFRIP6K1IP6K3IP6K2ALDH1A1
SCHEMBL30405798 0.75 OPRD1 (0.43) ALDH1A1CYP1A2CYP3A4USP2CYP2C19
SCHEMBL25229495 0.74 PDGFRB (0.39) EGFRIP6K1IP6K3IP6K2ALDH1A1
SCHEMBL24010092 0.74 ACHE (0.59) ACHEBACE1AURKAMAPK1
SCHEMBL25272648 0.71 KIT (0.49) ALDH1A1CYP1A2CYP3A4USP2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023107696-A2 INHIBITORS OF MENIN-MLL INTERACTION BALA THERAPEUTICS, INC. (US) 2023-06-15 — — WO disclosed
Send feedback